Skip to main content
letter
. 2015 Dec 18;29(1):140–146. doi: 10.1177/0394632015622215

Table 3.

Secondary outcome: the participants who were taking NSAIDS and anti-COX-2 drugs.

Intake of NSAIDS and ANTI-COX-2 drugs per day T0 T1 T2
MB group 26 18 16
GS group 24 14 14
Chi-square 0.26 0.58 0.21
P 0.61 0.447 0.643

No significant differences in the groups at the time of measurement.

The statistic comparison between the two groups at three different follow-ups (T0 = recruitment; T1 = 2 months; T2 = 6 months).

Significance value of P <0.05.